Today we’re announcing a new study to advance research on lung cancer. While lung cancer research and targeted therapies have provided hope and progress for many, this study aims to learn more about the genetics behind the disease and its causes. More:
23andMe researchers able to predict whether a person had Parkinson’s or not 80% of the time based on the amount and diversity of microbes in samples using Random Forest:
"The genetic testing didn’t just save my life, it saved my family. I mean, many of them now can catch it early and live a lot longer. So, science is great.”
#BreastCancerAwarenessMonth
So excited to see the new paper from
@23andMe
on
#LongCOVID
out! Three new hits of which two are at loci earlier associated with COVID-19 (ABO and HLA loci), and one additional super exciting at the BPTF locus. Congrats
@ninaadsc
!
📌Publication alert: In a preprint from the
@23andMeResearch
team, we conducted one of the largest GWAS study of Long COVID and identified genetic links of chronic conditions with Long COVID.
Your upgrade to Total Health is here.
🧬 Advanced genetic sequencing
🎂 Biological age
🩸 In-depth blood testing
🩺 1:1 clinical care
Current 23andMe customers can now upgrade to Total Health, our newest longevity platform.
Today is World Alzheimer's Day. Did you know 40-65% of people diagnosed with Alzheimer's have at least one genetic variant called APOE4? Learn more here:
Your DNA is your journey. 🌍 Dive into your unique story with 23andMe and discover what makes you, you. Have an incredible ancestry discovery or a surprising genetic insight? Share your story with us in the comments and let's celebrate the journey together!
Sickle cell trait is not a disease. It's a risk factor for blood clotting but the risk is still very small, lower than for those with heterozygous factor V Leiden, says study author Dr. Rakhi Naik (
@redcell_doc
).
➡️
@BloodAdvances
@23andMe
@VenceBonham
Today, we remember and honor the lives lost on September 11th, 2001. 🇺🇸 We reflect on the bravery of the first responders, the resilience of the survivors, and the unity that brought us together in the face of tragedy.
23andMe inches closer to cancer immunotherapy, guided by its genetic database. Dr. Jennifer Low, head of 23andMe’s therapeutics division, talks about the development of oncology checkpoint inhibitors that target a unique pathway.
“My kit is ready to go in the mail! I am happy to be given this opportunity to contribute to the research of lung cancer & to help future generations including my children & grandchildren.”- Nikki
Sign up for the
@23andMe
lung cancer genetics study here:
We are at a pivotal juncture in the fight against lung cancer. The
#IASLC
is teaming up with
@23andMe
on a groundbreaking initiative to better understand how genetics could impact
#lungcancer
. Click here to learn more and sign up today:
#LCSM
Help us change the face of genetics research by telling us about your experience with
#lungcancer
. Learn more about our Lung Cancer Genetics Study with
@23andMe
and sign up today at:
#LCSM
There are so few things I have been able to control about this diagnosis but by participating in this study I get to CHOOSE to leave behind a legacy of HOPE!
@23andMe
I sent in my spit cup and am participating in
@23andme
lung cancer study. If you have or had
#lungcancer
, please participate so they get a rich database for researchers to study!!
My spit cup from
@23andMe
is arriving soon. I'm so excited to participate in their Lung Cancer Genetics Study! If you have or had
#lungcancer
, you can too.
#lcsm